User profiles for Merete Lund Hetland
 | Merete HetlandVerified email at dadlnet.dk Cited by 19847 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
…, L Gossec, JE Gottenberg, ML Hetland… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …
rheumatoid arthritis (RA) management recommendations to account for the most recent …
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab …
ML Hetland, IJ Christensen, U Tarp… - … : Official Journal of …, 2010 - Wiley Online Library
Objective To compare tumor necrosis factor α inhibitors directly regarding the rates of treatment
response, remission, and the drug survival rate in patients with rheumatoid arthritis (RA), …
response, remission, and the drug survival rate in patients with rheumatoid arthritis (RA), …
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial …
ML Hetland, B Ejbjerg, K Hørslev-Petersen… - Annals of the …, 2009 - ard.bmj.com
Objective: To identify predictors of radiographic progression in a 2-year randomised, double-blind,
clinical study (CIMESTRA) of patients with early rheumatoid arthritis (RA). Methods: …
clinical study (CIMESTRA) of patients with early rheumatoid arthritis (RA). Methods: …
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist …
…, E Lie, E Nasonov, G Lukina, ML Hetland… - Annals of the …, 2011 - ard.bmj.com
Objective To assess the 6-month effectiveness of the first rituximab (RTX) course in
rheumatoid arthritis (RA) and to identify possible predictors of response. Method 10 European …
rheumatoid arthritis (RA) and to identify possible predictors of response. Method 10 European …
Health-related quality of life: validity, reliability, and responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis
…, K Hørslev-Petersen, ML Hetland - The Journal of …, 2008 - jrheum.org
Objective To compare validity, reliability, and responsiveness of generic and disease specific
health-related quality of life (HRQOL) instruments in rheumatoid arthritis (RA). Methods …
health-related quality of life (HRQOL) instruments in rheumatoid arthritis (RA). Methods …
Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti–tumor necrosis factor α therapy: results from the …
…, T Lorenzen, ML Hetland - Arthritis & …, 2011 - Wiley Online Library
Objective To investigate disease activity, treatment response, and drug survival, and predictors
thereof, among Danish patients with psoriatic arthritis (PsA) receiving their first treatment …
thereof, among Danish patients with psoriatic arthritis (PsA) receiving their first treatment …
Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' …
…, L Dreyer, HL Kristensen, ML Hetland - Annals of the …, 2010 - ard.bmj.com
Objectives To use prospectively registered data from the Danish nationwide rheumatological
database (DANBIO) to describe disease activity, clinical response, treatment duration and …
database (DANBIO) to describe disease activity, clinical response, treatment duration and …
Low bone mass and high bone turnover in male long distance runners
ML Hetland, J Haarbo… - The Journal of Clinical …, 1993 - academic.oup.com
Running is a popular sport, but in some studies long distance running in women has been
related to reduced bone mass and a potential risk of osteoporosis. To investigate the impact of …
related to reduced bone mass and a potential risk of osteoporosis. To investigate the impact of …
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries
…, H Mäkinen, SMM Verstappen, ML Hetland… - Annals of the …, 2007 - ard.bmj.com
Objective: To conduct a cross-sectional review of non-selected consecutive outpatients with
rheumatoid arthritis (RA) as part of standard clinical care in 15 countries for an overview of …
rheumatoid arthritis (RA) as part of standard clinical care in 15 countries for an overview of …
A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO …
…, KL Grøn, NS Krogh, L Pedersen, ML Hetland - Annals of the …, 2017 - ard.bmj.com
Objectives According to guidelines, a nationwide non-medical switch from originator (INX,
Remicade) to biosimilar infliximab (Remsima, CT-P13) was conducted in Danish patients with …
Remicade) to biosimilar infliximab (Remsima, CT-P13) was conducted in Danish patients with …